To provide a compound having a MGAT inhibition effect useful as pharmaceuticals, or a physiologically acceptable salt thereof, and to provide a pharmaceutical composition containing the same.
A bicyclic pyrimidine compound represented by the formula (I) or a physiologically acceptable salt thereof is provided. In the formula (I), R1 represents a lower alkyl group which may be substituted and the like, R2 represents a hydrogen atom and the like, R3 represents a hydrogen atom and the like, R4 and R5 represent each independently a hydrogen atom and the like, X represents an oxygen atom and the like, Y represents -N(R9)Z- and the like, where R9 represents a hydrogen atom and the like, Z represents an oxygen atom and the like, m represents 1 and n represents 2.
TAKADA TAKASHI
Samejima Mutsumi
Masahiro Nitta
Kure Hidenori